|
PRESS RELEASES AND OTHER NEWS
|
|
APRIL 22, 2009 |
Halo Completes $14.6 Million in Financing.
Halo Pharmaceutical, this week announced that it has completed $14.6 million in financing from The Provident Bank to expand its operations.
READ MORE  |
APRIL 20, 2009 |
Halo Welcomes Dr. George Bobotas as its Chief Scientific Officer.
As part of a Research and Development partnership between Halo Pharmaceutical and DeMelleBioPharma, LLC, Dr. George Bobotas joins Halo Pharmaceutical as Chief Scientific Officer.
READ MORE |
MARCH 3, 2009 |
Halo Launched in Canada.
Halo has announced today that it is establishing a Canadian subsidiary to be called Halo Pharmaceutical Marketing (Canada) Ltd.
READ MORE |
JANUARY 26, 2009 |
Allen Rosenston appointed VP Business Development.
Adding to its strong executive team, Halo announced the addition of Allen M. Rosenston, a thirty-five year pharmaceutical industry veteran, as Halo's new Vice President of Business Development.
READ MORE |
JANUARY 6, 2009 |
Halo Pharmaceutical, Inc. Acquires Whippany Manufacturing Facility from Abbott.
Halo completes its acquisition of the Whippany-NJ Manufacturing and Research facility from Abbott.
READ MORE |
OCTOBER 7, 2008 |
Drug Enforcement Administration - Manufacturer of Controlled Substances; Notice of Registration
DEA has determined that the registration of Halo Pharmaceutical Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time.
READ MORE |